The US Food and Drug Administration approved the drug semaglutide in June 2021 under the brand names Wegovy for chronic weight management and Ozempic for type 2 diabetes mellitus
Published data (STEP 4 trial, JAMA 2022) show that most patients regain a portion of lost weight after discontinuation
The sense of belonging to a defined club can boost self-efficacyyour belief in your ability to succeedwhich research links to better diet adherence and more physical activity
Prokinetic agents such as metoclopramide or domperidone, which accelerate gastric emptying, may counteract some of the therapeutic effects of semaglutide on satiety and weight loss
GLP-1 is a naturally occurring hormone that helps regulate blood sugar and feelings of satiety
Its a term that has been popularized on social media, said Amanda Velazquez, MD, director of Obesity Medicine at Cedars-Sinai